Cloud Capital Management’s Harmony Biosciences HRMY Stock Holding History

Cloud Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6	Closed	–	–	730
2025 Q3	$0	Buy	+6	New	+$207	﹤0.01%	1233

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cloud Capital Management's HRMY Position: Q4 2025 in Review

Cloud Capital Management sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 6 shares.

Cloud Capital Management first reported a position in HRMY in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 325 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

Cloud Capital Management reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
Cloud Capital Management sold 6 Harmony Biosciences shares in Q4 2025.
Cloud Capital Management first reported a position in Harmony Biosciences in Q3 2025 and held it in 1 quarter.
Cloud Capital Management's Harmony Biosciences position peaked at $0 in Q3 2025.
325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.